Recent News

• 08.12.2025 - BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.12.2025 - BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.05.2025 - BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
• 08.05.2025 - BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
• 06.18.2025 - BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
• 06.18.2025 - BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
• 06.17.2025 - BioRestorative Announces Share Repurchase Program
• 06.17.2025 - BioRestorative Announces Share Repurchase Program
• 06.13.2025 - BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
• 06.13.2025 - BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Recent Filings

• 08.08.2025 - DEF 14A Other definitive proxy statements
• 06.13.2025 - EX-99.1 EX-99.1
• 06.13.2025 - 8-K Current report
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors